CORRELATION BETWEEN CLINICAL AND LABORATORY CHARACTERISTICS IN PATIENTS WITH OCULAR MYASTHENIA GRAVIS

Nguyễn Văn Tuận1,, Triệu Thị Tạo2
1 Department of Neurology, Bach Mai Hospital
2 Thai Nguyen Central General Hospital

Main Article Content

Abstract

Ocular Myasthenia Gravis is a neuromuscular disorder that is often the beginning of generalized myasthenia gravis. Objectives: To analyze the correlation between the clinical and subclinical characteristics in patients with ocular myasthenia gravis. Subjects and methods: We studied 43 patients with ocular myasthenia gravis treated at Bach Mai Hospital's Neurological Center. Results: Females accounted for 65.1%, males 34.9%, and the mean age was 44.7 ± 14.3. Test neostigmine was positive at 88.4%. The repetitive nerve stimulation test (KTTKLT) was positive for the eye myasthenia gravis at 30.8%, for the generalized myasthenia gravis group at 80%. Anti-acetylcholine receptor (AChR Ab) antibody test was positive for ocular myasthenia gravis at 76.9%, with the generalized myasthenia gravis at 93.3%. There was a correlation between disease duration, ptosis location, and the type of myasthenia gravis (p<0.05), respectively OR (95%CI) was 15.7 (1.8-136.6) and 7,4 (1.7-31.5%). There is a correlation between KTTKLT, the AChR Ab test, and the severity of myasthenia gravis according to Osserman's classification (p<0.05), the corresponding OR (95%CI) is 9.0 (2.1 - 39.5) and 4.2 (1.2 - 28.9). Conclusion: The ophthalmic myasthenia gravis with a positive diagnostic test is still low, so it is necessary to distinguish it from other diseases.

Article Details

References

1. Phan Thanh Hiếu, Phan Việt Nga, Nhữ Đình Sơn, Nguyễn Giang Nam, Đỗ Khắc Đại. Đánh giá nồng độ tự kháng thể kháng thụ cảm thể acetylcholin ở bệnh nhân nhược cơ. Tạp chí Y học Việt Nam. 2014;9(1):32-35.
2. Fan L, Ma S, Yang Y, Yan Z, Li J, Li Z. Clinical differences of early and late-onset myasthenia gravis in 985 patients. Neurol Res. 2019;41(1):45-51. doi:10.1080/01616412.2018.1525121
3. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023-1036. doi:10.1016/S1474-4422(15)00145-3
4. Kim KH, Kim SW, Shin HY. Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis. J Clin Neurol Seoul Korea. 2021;17(2):265-272. doi:10.3988/jcn.2021.17.2.265
5. Lefvert AK, Bergström K, Matell G, Osterman PO, Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry. 1978;41(5):394-403
6. Osserman KE. Ocular Myasthenia Gravis. Invest Ophthalmol Vis Sci. 1967;6(3):277-287.
7. Ullah U, Iftikhar S, Javed MA. Relationship between Low and High Anti-acetylcholine Receptor Antibody Titers and Clinical Severity in Myasthenia Gravis. J Coll Physicians Surg--Pak JCPSP. 2021;31(8):965-968. doi:10.29271/jcpsp.2021.08.965
8. Wang W, Chen YP, Wei DN. [The clinical characteristics of early-onset versus late-onset types of myasthenia gravis]. Zhonghua Nei Ke Za Zhi. 2011;50(6):496-498. doi:10.3760/ cma.j.issn.0578-1426.2011.06.013